1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)oxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl- 2,5,7-trihydroxy-4-[(2S,3R,4R,5R,6S)-4-hydroxy-3,5-dimethoxy-6-methyl-tetrahydropyran-2-yl]oxy-3,9-dimethoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione 54526-94-2 NSC204855 Steffimycin B U 40615
| CAS 号 | 54526-94-2 |
| 分子式 | C29H32O13 |
| 分子量 | 588.56 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
(1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)oxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl- 2,5,7-trihydroxy-4-[(2S,3R,4R,5R,6S)-4-hydroxy-3,5-dimethoxy-6-methyl-tetrahydropyran-2-yl]oxy-3,9-dimethoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione 54526-94-2 NSC204855 Steffimycin B U 40615)是药物分析与质量控制领域常用的药物标准品,CAS 号 54526-94-2。分子式 C29H32O13,分子量 588.56。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录,可一站式满足配套采购需求。
与同类药物标准品相比,的分子量为588.56 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 (1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)oxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl- 2,5,7-trihydroxy-4-(2S,3R,4R,5R,6S)-4-hydroxy-3,5-dimethoxy-6-methyl-tetrahydropyran-2-yloxy-3,9-dimethoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione 54526-94-2 NSC204855 Steffimycin B U 40615),CAS注册编号 54526-94-2,化学分子式为 C29H32O13,分子量 588.56 g/mol。 受分子结构中羧酸类,含羟基,含醚键,多环芳烃的影响,表现为淡黄色至黄色结晶性粉末。其固体形态的物理
应用场景:(1,6,11(2H)-Naphthacenetrione, 4-((6-deoxy-2,4-di-O-methyl-alpha-L-mannopyranosyl)oxy)-3,4-dihydro-2,5,7-trihydroxy-3,9-dimethoxy-2-methyl- 2,5,7-trihydroxy-4- (2S,3R,4R,5R,6S)-4-hydroxy-3,5-dimethoxy-6-methyl-tetrahydropyran-2-yl oxy-3,9-dimethoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione 54526-9
| 中文名称 | |
| 分子式 | C29H32O13 |
| 分子量 | 588.56 g/mol |
| 外观形态 | 淡黄色至黄色结晶性粉末 |
| 纯度 | 97%+ |
| 储存条件 | 室温保存,避光,密封防潮 |
| 溶解性参考 | 可溶于甲醇、乙腈、DMSO、水(微溶) |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 14.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份(估) | 1972年 |